
|Articles|February 6, 2004
AADA urges FDA crackdown of internet-based isotretinoin sales
Schaumburg, Ill. - The American Academy of Dermatology Association (AADA)urged the FDA to stop internet sales of isotretinoin, the active ingredientin Accutane, arguing that such sales pose potential health risks to thepublic. The statement was released at the AAD 2004 annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
4
Interim Analysis Leads to Early Termination of DUPLEX-AD Study
5


















